Charts Thiogenesis Therapeutics, Corp.

Stocks

Delayed Toronto S.E. Other stock markets 15:24:19 15/07/2026 BST			5-day change	1st Jan Change
0.5300 ^CAD	-7.02%		-5.36%	-18.46%

07-13	Thiogenesis Therapeutics Receives Fda Rare Pediatric Disease Designation for Tti-0102 for the Treatment of Leigh Syndrome	CI
07-13	Thiogenesis Therapeutics' Treatment For Leigh Syndrome Receives FDA Rare Pediatric Disease Designation	MT

ProRealTime Chart